Domoksin
Izgled
(IUPAC) ime | |||
---|---|---|---|
1-benzil-1-(2,3-dihidro-1,4-benzodioksin-2-ilmetil)hidrazin | |||
Klinički podaci | |||
Identifikatori | |||
CAS broj | 61-74-5 | ||
ATC kod | nije dodeljen | ||
PubChem[1][2] | 208853 | ||
ChemSpider[3] | 180960 | ||
Hemijski podaci | |||
Formula | C16H18N2O2 | ||
Mol. masa | 270,326 g/mol | ||
SMILES | eMolekuli & PubHem | ||
| |||
Farmakoinformacioni podaci | |||
Trudnoća | ? | ||
Pravni status |
Domoksin (INN) je derivat hidrazina. On je antidepresiv koji deluje kao inhibitor monoaminske oksidaze (MAOI). On nije plasiran na tržište.[4]
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.
- ↑ World Health Organization (2011). „The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances” (PDF). Pristupljeno 2012/05/20.